This makes IL-6 a possible candidate for an intermediary between systemic and local responses, as well as between the metabolic and inflammatory pathways, suggesting that IL-6 acts as a key initiator and regulator of metabolic and immune responses in MI [39, 41]. The gene discussed is IL6; the disease is myocardial infarction.